S. Maxwell et al., COMPARISON OF ANTIOXIDANT ACTIVITY IN LIPOPROTEIN FRACTIONS FROM INSULIN-DEPENDENT DIABETICS AND HEALTHY CONTROLS, Atherosclerosis, 129(1), 1997, pp. 89-96
The insulin-dependent diabetic patient is at greatly increased risk of
premature atherosclerosis. Oxidative damage to lipoproteins has been
implicated as an important factor in the atherogenic process. Diabetic
patients are exposed to excessive oxidative stress because of non-enz
ymatic glycation of proteins and a variety of defects in antioxidant s
ystems. We have previously described an enhanced chemiluminescent meth
od for measuring protective 'chain-breaking' antioxidant activity in p
lasma lipoprotein fractions. In this study we compare the lipid conten
t and antioxidant activity of plasma lipoproteins in 22 young insulin-
dependent diabetics without vascular complications and 20 age- and sex
-matched controls. Mean levels of haemoglobin Ale in the diabetic grou
p were 8.8 +/- 0.2%. There were no significant differences in serum to
tal cholesterol, apolipoprotein A, apolipoprotein B or lipoprotein(a)
levels between the study groups. Serum total triglyceride levels (1.32
+/- 0.11 versus 1.01 +/- 0.08 mmol/l; P < 0.05) and LDL-associated tr
iglyceride (0.28 +/- 0.04 versus 0.15 +/- 0.02 mmol/l; P < 0.05) were
significantly elevated in the diabetic group. Total plasma antioxidant
activity was significantly reduced in the diabetic group (272.0 +/- 1
5.4 versus 338.3 +/- 20.7 mu mol/l; P < 0.05). Antioxidant activity me
asured in five lipoprotein fractions isolated by density gradient ultr
acentrifugation (VLDL1, VLDL2, LDL1, LDL2 and HDL) showed no significa
nt differences between groups when corrected for protein, total lipid
or cholesterol content. When corrected for triglyceride content signif
icantly lower antioxidant values were found in the diabetic HDL fracti
on only. The results of this study imply that the susceptibility of th
e insulin-dependent diabetic to the development of premature atheroscl
erosis cannot be attributed to reduced antioxidant activity in circula
ting plasma lipoproteins. (C) 1997 Elsevier Science Ireland Ltd.